Natural Product (NP) Details
General Information of the NP (ID: NP3889) | |||||
---|---|---|---|---|---|
Name |
Rutin
|
||||
Synonyms |
rutoside; Phytomelin; Quercetin 3-rutinoside; Birutan; Eldrin; Rutin trihydrate; Myrticolorin; Venoruton; Bioflavonoid; Paliuroside; Tanrutin; Osyritrin; Rutine; Rutozyd; 3-Rutinosyl quercetin; 3-Rhamnoglucosylquercetin; Quercetin 3-O-rutinoside; Rutosido; Rutosidum; Rutinum; Globularicitrin; Quercetin-3-rutinoside; Rutabion; Violaquercitrin; Globulariacitrin; Melin; Rutinic acid; Birutan Forte; Birutin; Quercetin rhamnoglucosine; Quercetin-3beta-rutinoside; UNII-5G06TVY3R7; Oxyritin; Rutosid; Ilixanthin; Rutinion acid
Click to Show/Hide
|
||||
Species Origin | Fagopyrum esculentum ... | Click to Show/Hide | |||
Fagopyrum esculentum | |||||
Adiantum capillus-veneris | |||||
Averrhoa carambola | |||||
Amorpha fruticosa | |||||
Bupleurum chinense | |||||
Ficus pumila | |||||
Boehmeria nivea | |||||
Apocynum venetum | |||||
Caragana rosea | |||||
Cirsium setosum | |||||
Disease | Acute lymphoblastic leukemia [ICD-11: 2B33] | Investigative | [1] | ||
Structure |
![]() |
Click to Download Mol2D MOL |
|||
Click to Show/Hide the Molecular Information and External Link(s) of This Natural Product | |||||
Formula |
C27H30O16
|
||||
PubChem CID | |||||
Canonical SMILES |
CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3=C(OC4=CC(=CC(=C4C3=O)O)O)C5=CC(=C(C=C5)O)O)O)O)O)O)O)O
|
||||
InChI |
1S/C27H30O16/c1-8-17(32)20(35)22(37)26(40-8)39-7-15-18(33)21(36)23(38)27(42-15)43-25-19(34)16-13(31)5-10(28)6-14(16)41-24(25)9-2-3-11(29)12(30)4-9/h2-6,8,15,17-18,20-23,26-33,35-38H,7H2,1H3/t8-,15+,17-,18+,20+,21-,22+,23+,26+,27-/m0/s1
|
||||
InChIKey |
IKGXIBQEEMLURG-NVPNHPEKSA-N
|
||||
CAS Number |
CAS 153-18-4
|
||||
Herb ID | |||||
ETMC ID | |||||
SymMap ID | |||||
TCMSP ID | |||||
TTD Drug ID |
Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
---|---|---|---|---|---|---|
α. A List of Drug(s) Whose Efficacy can be Enhanced by This NP | ||||||
5-fluorouracil | Solid tumour/cancer | Click to Show/Hide the Molecular Data of This Drug | ||||
Achieving Therapeutic Synergy | Click to Show/Hide | |||||
Representative Experiment Reporting the Effect of This Combination | [2] | |||||
Detail(s) |
Combination Info
![]() |
|||||
Molecule(s)
Regulation |
Down-regulation | Expression | BCL-2 | Molecule Info |
Pathway MAP
|
|
Up-regulation | Expression | TP53 | Molecule Info |
Pathway MAP
|
||
In-vitro Model | PC-3 | CVCL_0035 | Prostate carcinoma | Homo sapiens | ||
Experimental
Result(s) |
Synergistic effects of 5-FU/rutin combination on PC3 cells line enhanced apoptosis, p53 gene expression, and down-regulation of Bcl-2 protein, compared to control separate application. |
Target and Pathway | ||||
---|---|---|---|---|
Target(s) | Dihydrodiol dehydrogenase I (AKR1C3) | Molecule Info | [3] | |
BioCyc | Superpathway of steroid hormone biosynthesis | Click to Show/Hide | ||
2 | Allopregnanolone biosynthesis | |||
3 | Androgen biosynthesis | |||
KEGG Pathway | Steroid hormone biosynthesis | Click to Show/Hide | ||
2 | Arachidonic acid metabolism | |||
3 | Metabolic pathways | |||
4 | Ovarian steroidogenesis | |||
NetPath Pathway | TGF_beta_Receptor Signaling Pathway | Click to Show/Hide | ||
Pathwhiz Pathway | Arachidonic Acid Metabolism | Click to Show/Hide | ||
Reactome | Retinoid metabolism and transport | Click to Show/Hide | ||
WikiPathways | Metapathway biotransformation | Click to Show/Hide | ||
2 | Benzo(a)pyrene metabolism | |||
3 | Arachidonic acid metabolism |

